Cancer Vaccines 2022

Authored by
Last reviewed
February 18, 2022

Cancer Vaccines for 2022

The US Centers for Disease Control and Prevention (CDC) recommends cancer-prevention vaccinations for most people, such as Human Papillomavirus (HPV) vaccines and Hepatitis B.

And people with cancer or other diseases that compromise the immune system should ask their doctor about pneumococcal vaccination options. Furthermore, the annual flu shot has a long, established safety record in people with cancer, says the CDC.

Types of Cancer Vaccines

Many cancer vaccines are a form of immunotherapy that educates the human immune system about what cancer cells "look like" so that it can recognize and help eliminate them, says the Cancer Research Insitute's website. Cancer vaccines included preventive, therapeutic, and personalized options.

Cancer Vaccine Library for 2022

The PrecisionVaccinations vaccine library includes information published in 2022 from the U.S. FDA, European Medicines Agency, Brazil, Russia, India, China, and many other countries.

Click here to access the A-Z vaccine library.

Cancer Vaccine Discounts

The portal empowers quick access to vaccine and medication discount vendors.

    Cancer Vaccine News For 2022

    Feb. 18. 2022 - Moderna's new checkpoint cancer vaccine candidate (mRNA-4359) expresses Indoleamine 2,3-dioxygenase and programmed death-ligand 1 antigens. Moderna designed mRNA-4359 with the goal of stimulating effector T-cells that target and kill suppressive immune and tumor cells that express target antigens. Moderna is planning to explore initial indications for advanced or metastatic cutaneous melanoma and non-small cell lung carcinoma.

    Melanoma is the fifth most common cancer diagnosis in the U.S. It accounts for 5.3% of all new cancer diagnoses and 1.5% of all cancer-related deaths. 

    Feb. 17, 2022 - Celsion Corporation announced the Data Safety Monitoring Board has unanimously recommended that the OVATION 2 Study continue treating patients with the dose of 100 mg/m2. 

    Feb.17, 2022 - Applied DNA Sciences Inc. and EvviVax SRL published a preclinical study showing that LinearDNA vaccines used for cancer immunotherapy produced a strong immune and specific antitumoral response in preclinical mouse models.

    Feb. 17, 2022 - Northwest Biotherapeutics announced the commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its recently licensed production facility in Sawston, UK.

    Types of Cancers

    Researchers are testing vaccines and immunotherapies for several types of cancers:

    Bladder cancer: Researchers are studying the effectiveness of a vaccine made from a virus modified to contain HER2 cells.

    Brain tumors: Many studies test treatment vaccines aimed at specific molecules on the surface of brain tumor cells.

    Breast cancer: Several studies test treatment vaccines for breast cancer, given alone or with other therapies.

    Cervical cancer: The FDA has approved cervical cancer prevention vaccines.

    Colorectal cancer: Researchers create treatment vaccines that encourage the body to attack cells with antigens thought to cause colorectal cancer.

    Kidney cancer: Researchers are testing the use of several cancer vaccines to treat kidney cancer. They are also testing vaccines to prevent later-stage kidney cancer from recurring.

    Leukemia: Studies are looking at treatment vaccines for various leukemia types, such as acute myeloid leukemia and chronic lymphocytic leukemia.

    Lung cancer: Lung cancer treatment vaccines in clinical trials target antigens.

    Melanoma: Researchers are testing destroying melanoma cells, and antigens in the vaccines encourage the immune system to destroy other melanoma cells in the body.

    Pancreatic cancer: Researchers work on several treatment vaccines to boost the immune system's response to pancreatic cancer cells.

    Prostate cancer: Sipuleucel-T is a vaccine doctors use to treat men with metastatic prostate cancer. Now researchers are studying if the vaccine can help men with less advanced prostate cancer.

    Note: This content is reviewed for clinical efficacy by healthcare providers.